Foster Dykema Cabot & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $725K | Buy |
4,652
+733
| +19% | +$121K | 0.09% | 47 |
|
|
2023
Q2 | $649K | Hold |
3,919
| – | – | 0.08% | 54 |
|
|
2023
Q1 | $607K | Buy |
3,919
+160
| +4% | +$25.8K | 0.08% | 50 |
|
|
2022
Q4 | $664K | Sell |
3,759
-4,315
| -53% | -$745K | 0.09% | 46 |
|
|
2022
Q3 | $1.32M | Sell |
8,074
-565
| -7% | -$95.6K | 0.17% | 40 |
|
|
2022
Q2 | $1.53M | Sell |
8,639
-71
| -0.8% | -$12.7K | 0.19% | 35 |
|
|
2022
Q1 | $1.54M | Sell |
8,710
-2,564
| -23% | -$436K | 0.19% | 40 |
|
|
2021
Q4 | $1.93M | Hold |
11,274
| – | – | 0.22% | 37 |
|
|
2021
Q3 | $1.82M | Sell |
11,274
-84
| -0.7% | -$14.3K | 0.23% | 40 |
|
|
2021
Q2 | $1.87M | Sell |
11,358
-577
| -5% | -$95.5K | 0.23% | 39 |
|
|
2021
Q1 | $1.96M | Buy |
11,935
+1,008
| +9% | +$163K | 0.27% | 37 |
|
|
2020
Q4 | $1.72M | Sell |
10,927
-1,019
| -9% | -$150K | 0.24% | 41 |
|
|
2020
Q3 | $1.78M | Hold |
11,946
| – | – | 0.29% | 33 |
|
|
2020
Q2 | $1.68M | Buy |
11,946
+107
| +0.9% | +$15.6K | 0.3% | 32 |
|
|
2020
Q1 | $1.55M | Hold |
11,839
| – | – | 0.3% | 31 |
|
|
2019
Q4 | $1.73M | Sell |
11,839
-3,121
| -21% | -$423K | 0.24% | 34 |
|
|
2019
Q3 | $1.94M | Sell |
14,960
-1,294
| -8% | -$170K | 0.29% | 34 |
|
|
2019
Q2 | $2.26M | Sell |
16,254
-145
| -0.9% | -$20.1K | 0.34% | 30 |
|
|
2019
Q1 | $2.29M | Hold |
16,399
| – | – | 0.37% | 26 |
|
|
2018
Q4 | $2.12M | Buy |
16,399
+660
| +4% | +$92.1K | 0.38% | 25 |
|
|
2018
Q3 | $2.17M | Sell |
15,739
-838
| -5% | -$111K | 0.35% | 26 |
|
|
2018
Q2 | $2.19M | Sell |
16,577
-872
| -5% | -$109K | 0.37% | 25 |
|
|
2018
Q1 | $2.24M | Sell |
17,449
-96
| -0.5% | -$13K | 0.38% | 30 |
|
|
2017
Q4 | $2.45M | Buy |
17,545
+134
| +0.8% | +$18.7K | 0.41% | 29 |
|
|
2017
Q3 | $2.26M | Sell |
17,411
-85
| -0.5% | -$11.3K | 0.4% | 29 |
|
|
2017
Q2 | $2.31M | Buy |
17,496
+36
| +0.2% | +$4.59K | 0.41% | 30 |
|
|
2017
Q1 | $2.17M | Sell |
17,460
-100
| -0.6% | -$11.9K | 0.4% | 30 |
|
|
2016
Q4 | $2.02M | Sell |
17,560
-840
| -5% | -$97K | 0.38% | 34 |
|
|
2016
Q3 | $2.17M | Sell |
18,400
-120
| -0.6% | -$14.6K | 0.47% | 37 |
|
|
2016
Q2 | $2.25M | Sell |
18,520
-750
| -4% | -$85.2K | 0.52% | 33 |
|
|
2016
Q1 | $2.08M | Sell |
19,270
-10
| -0.1% | -$1.03K | 0.51% | 31 |
|
|
2015
Q4 | $1.98M | Sell |
19,280
-440
| -2% | -$44.2K | 0.5% | 30 |
|
|
2015
Q3 | $1.84M | Sell |
19,720
-485
| -2% | -$46.9K | 0.47% | 31 |
|
|
2015
Q2 | $1.97M | Sell |
20,205
-750
| -4% | -$75.1K | 0.51% | 31 |
|
|
2015
Q1 | $2.11M | Hold |
20,955
| – | – | 0.52% | 31 |
|
|
2014
Q4 | $2.19M | Sell |
20,955
-715
| -3% | -$75.3K | 0.52% | 31 |
|
|
2014
Q3 | $2.31M | Sell |
21,670
-3,570
| -14% | -$370K | 0.56% | 31 |
|
|
2014
Q2 | $2.64M | Buy |
25,240
+992
| +4% | +$100K | 0.63% | 31 |
|
|
2014
Q1 | $2.38M | Buy |
24,248
+150
| +0.6% | +$13.9K | 0.59% | 30 |
|
|
2013
Q4 | $2.21M | Sell |
24,098
-216
| -0.9% | -$19.9K | 0.59% | 31 |
|
|
2013
Q3 | $2.11M | Sell |
24,314
-260
| -1% | -$23.3K | 0.61% | 32 |
|
|
2013
Q2 | $2.11M | Buy |
+24,574
| New | +$2.09M | 0.63% | 30 |
|
Other funds holding JNJ
Foster Dykema Cabot & Co's JNJ Position: Q3 2023 in Review
Foster Dykema Cabot & Co increased its Johnson & Johnson (JNJ) stake by 19% in Q3 2023, buying an estimated $121K and bringing the position to 4,652 shares worth $725K. The position accounts for 0.09% of the portfolio, ranked #47.
Foster Dykema Cabot & Co first reported a position in JNJ in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.64M in Q2 2014. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.
- Foster Dykema Cabot & Co held 4,652 shares of Johnson & Johnson worth $725K as of Q3 2023.
- Foster Dykema Cabot & Co bought 733 Johnson & Johnson shares in Q3 2023, an estimated $121K.
- Johnson & Johnson made up 0.09% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #47 holding.
- Foster Dykema Cabot & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 42 quarters since.
- Foster Dykema Cabot & Co's Johnson & Johnson position peaked at $2.64M in Q2 2014.
- 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.